Everest Organics

What Everest Organics does

Everest Organics Limited is a publicly listed (BSE since 1995) Indian pharmaceutical manufacturer founded in 1993 that produces Active Pharmaceutical Ingredients (APIs) and intermediates at a USFDA-approved facility in Sadasivpet, Telangana, with a corporate office in Madhapur, Hyderabad. The company's core technology centers on complex multi-step synthesis, hydrogenation, catalyst-based reactions, low- and high-temperature reaction management, and chemical/enzymatic resolution, supporting a portfolio of 30+ APIs and 32+ intermediates spanning gastroenterology (e.g., Omeprazole, Pantoprazole Sodium Sesquihydrate, Esomeprazole Magnesium Trihydrate), hypercholesterolemia, anti-viral (Oseltamivir, Remdesivir, Molnupiravir), antifungal (Posaconazole), and anti-thrombotic therapeutic areas. Manufacturing is supported by zero-liquid discharge effluent management, 5.5 acres of solar generation, and multi-jurisdictional regulatory filings (US DMF, EU DMF, CEP, China DMF).

The company earns revenue through three streams: catalog API product sales, intermediate and key starting material sales, and CDMO/CRAMS contract development and manufacturing services that include custom synthesis of small molecules, NCE production support, co-development, and process scale-up from laboratory to commercial scale. Pricing is quote-based and negotiated per contract; standard packing is 25kg HDPE drums, with delivery typically three to four weeks from confirmed order. Go-to-market is exclusively direct B2B enterprise sales targeting multinational pharmaceutical companies and formulation firms in India, Europe, the US, the Far East, the Middle East, and Latin/Central/South America, conducted through dedicated email contacts, technical discussions, sample provision, and site visits, with investor communications via BSE filings under SEBI LODR requirements.

Name

Everest Organics

Legal name

Everest Organics Limited

Website

https://everestorganicsltd.com

Company type

Public

Founded year

1993

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Everest Organics Limited is a publicly listed Indian manufacturer of 30+ APIs and 32+ intermediates at a USFDA-approved facility in Telangana, serving global pharmaceutical companies through direct B2B sales and CDMO/CRAMS services.

Ownership category

akta.pro rank

Product category

Pharmaceutical API Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541), All Other Basic Organic Chemical Manufacturing (325199)

SIC

Industrial Organic Chemicals (2860)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industries

Small-Molecule API & Intermediates CDMO (HLAGABAA), Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)

Keywords

• Active pharmaceutical ingredients
• Pharmaceutical intermediates
• Contract manufacturing services
• Key starting materials
• Custom synthesis APIs

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. API Product Sales: Sale of manufactured Active Pharmaceutical Ingredients (APIs) including Omeprazole, Pantoprazole Sodium Sesquihydrate, Esomeprazole Magnesium Trihydrate, and others across gastroenterology, hypercholesterolemia, and other therapeutic categories.
2. Intermediate Product Sales: Sale of key starting materials and pharmaceutical intermediates including Febuxostat Intermediates, Ilaprazole Intermediates, Imatinib Intermediates, and other custom intermediates.
3. CDMO/CRAMS Services: Contract Development and Manufacturing services providing custom synthesis, NCE production support, co-development, and custom synthesis for pharmaceutical companies looking to outsource API manufacturing.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Everest Organics manufactures Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates at a USFDA-approved facility in Sadasivpet, Hyderabad. The company supplies 30+ APIs and 32+ key starting materials/intermediates, and provides CDMO/CRAMS services including custom synthesis, co-development, and scale-up support for pharmaceutical companies globally.

Product overview

Everest Organics is a pharmaceutical manufacturer offering a diversified portfolio of 30+ Active Pharmaceutical Ingredients (APIs) across therapeutic areas including Gastroenterology and Hypercholesterolemia, alongside 32+ Intermediates and Key Starting Materials for drugs like Febuxostat, Ilaprazole, and Imatinib. The company provides Contract Research and Manufacturing Services (CRAMS) and Contract Development & Manufacturing Organization (CDMO) services, enabling co-development, custom synthesis, and end-to-end manufacturing support for pharmaceutical clients globally.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Portfolio of 30+ APIs and 32+ intermediates across various therapeutic categories
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Natco Pharma: Indian specialty generic and API manufacturer with USFDA approvals competing in similar therapeutic categories including gastroenterology; comparable in API scale and export orientation.
• Sai Life Sciences: Indian CDMO focused on complex small-molecule APIs and intermediates for innovator pharma; comparable in multi-step synthesis capabilities and process development services.
• Granules India: Indian API and finished formulation manufacturer with USFDA approvals supplying global generic pharma; comparable in therapeutic categories, DMF strategy, and B2B sales motion.
• Hikal Limited: Indian CDMO and API manufacturer serving global pharma with USFDA-approved facilities; closely comparable in custom synthesis, intermediates, and contract manufacturing offerings.
• Neuland Laboratories: Indian API manufacturer with USFDA and EDQM approvals supplying global generic and innovator pharma; comparable in therapeutic category breadth and CDMO service offering.
• Laurus Labs: Hyderabad-based API and CDMO peer with USFDA-approved facilities, multi-DMF portfolio, and growing contract development services; competes directly with Everest Organics in generic APIs and intermediates.
• Divi's Laboratories: Indian API and intermediate manufacturer with strong CDMO/CRAMS business serving global pharma; comparable in API portfolio breadth, multi-jurisdictional regulatory filings, and process chemistry capabilities.
• Jubilant Pharmova: Indian pharmaceutical company with CDMO, API, and radiopharma businesses holding multi-jurisdictional regulatory approvals; directly comparable in CDMO services and US DMF portfolio strategy.

Regional players

• Ajanta Pharma: Indian pharma company with API manufacturing and emerging markets focus; comparable in generic API scale but with greater emerging-markets orientation versus Everest Organics' regulated-market focus.

Broad incumbents

• Aurobindo Pharma: Large Indian generic pharma manufacturer with extensive USFDA-approved API facilities and broad DMF portfolio; broader in finished formulations but competes for the same API customers and regulatory approvals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/everest-organics-ltd

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Everest Organics